Alloimmunization as a barrier to gene therapy in sickle cell disease
Transfusion · 2025
DOI: 10.1111/trf.18266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Hannah R Abrams und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Genetic Therapy, Isoantibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Alloimmunization is prevalent in patients with sickle cell disease (SCD) and can be a barrier to gene therapy (GT) due to the necessary transfusion support for successful stem cell collection and infusion. We estimate that standard‐of‐care GT for an adult with SCD will require an average of 35–45 units of red blood cells over a 6‐month period. Institutions should actively plan for these transfusion needs and share information to inform national consensus policies on the management of alloimmunization during GT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, USA.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- Department of Laboratory Medicine and Pathology, Seattle Children's, Seattle, Washington, USA.
- University of Washington School of Medicine, Seattle, Washington, USA.
- Department of Medicine, Division of Hematology and Oncology, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Hannah R Abrams, Nabiha H Saifee, Rida A Hasan
Förderung
- NCI NIH HHS
Zitieren
APA
Abrams, H. R., Saifee, N. H., Miller, W. S., Cortez, A., Hasan, R. A., Panch, S. R., & Fertrin, K. Y. (2025). Alloimmunization as a barrier to gene therapy in sickle cell disease. Transfusion. https://doi.org/10.1111/trf.18266
Vancouver
Abrams HR, Saifee NH, Miller WS, Cortez A, Hasan RA, Panch SR, et al. Alloimmunization as a barrier to gene therapy in sickle cell disease. Transfusion. 2025. doi:10.1111/trf.18266
BibTeX
@article{Abrams2025,
author = {Abrams, Hannah R and Saifee, Nabiha H and Miller, William S and Cortez, Antonio and Hasan, Rida A and Panch, Sandhya R and Fertrin, Kleber Y},
title = {Alloimmunization as a barrier to gene therapy in sickle cell disease},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18266}
}
EUVIMED